You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenocarcinoma, Mucinous

Showing 1 - 25 of 2,133
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mucinous Tumor, Colorectal Tumor, Appendiceal Tumor Trial in Philadelphia (Nivolumab, Ipilimumab)

Terminated
Has Results
  • Mucinous Adenocarcinoma of the Colon
  • Mucinous Adenocarcinoma of the Rectum
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Sep 26, 2022

Genetics of Appendix Cancer Study

Recruiting
  • Appendix Cancer
  • +14 more
  • Genetic profiling
  • Retrospective tissue procurement
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Feb 8, 2023

Secondary Malignant Tumor of Retroperitoneum, Secondary Malignant Tumor of Peritoneum, Pseudomyxoma Peritonei Trial in Cleveland

Not yet recruiting
  • Secondary Malignant Neoplasm of Retroperitoneum
  • +2 more
  • Intestinal, Multivisceral or Modified Multivisceral Transplantation
  • +3 more
  • Cleveland, Ohio
    Cleveland Clinic Digestive Disease & Surgery Institute (DDSI), C
Oct 10, 2023

Mucinous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Seoul (Bevacizumab + modified FOLFIRINOX)

Recruiting
  • Mucinous Ovarian Cancer
  • +2 more
  • Bevacizumab + modified FOLFIRINOX
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Dec 25, 2022

Pseudomyxoma Peritonei, Peritoneal Cancer, Mucinous Adenocarcinoma Trial (Bromelain, Acetylcysteine, Interventional radiology

Not yet recruiting
  • Pseudomyxoma Peritonei
  • +3 more
  • (no location specified)
Feb 28, 2022

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting
  • Advanced Solid Tumor
  • +18 more
  • (no location specified)
Aug 10, 2022

Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo

Not yet recruiting
  • Colorectal Adenocarcinoma
  • +2 more
  • Trondheim, Trondelag, Norway
  • +2 more
Aug 15, 2022

Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

Terminated
  • Ovarian Cancer
  • +21 more
  • Exercise Counseling
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 6, 2022

Liquid Biopsies and Tumor Molecular Profiling in Predicting

Recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +5 more
  • Biospecimen Collection
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 3, 2022

Peritoneal Cancer, Pseudomyxoma Peritonei, Mucinous Adenocarcinoma Trial in Lexington, Stony Brook (nanoliposomal irinotecan)

Completed
  • Peritoneal Cancer
  • +7 more
  • nanoliposomal irinotecan
  • Lexington, Kentucky
  • +1 more
May 5, 2022

Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Houston (drug,

Terminated
  • Rectal Mucinous Adenocarcinoma
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 21, 2022

Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles

Active, not recruiting
  • Mucinous Adenocarcinoma of the Rectum
  • +7 more
  • bevacizumab
  • +4 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Aug 5, 2022

Recurrent Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma Trial in

Recruiting
  • Recurrent Endometrial Adenocarcinoma
  • +8 more
  • Ipilimumab
  • Nivolumab
  • Iowa City, Iowa
  • +9 more
Jan 27, 2023

Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors Trial in

Not yet recruiting
  • Stage I Testicular Seminoma
  • +13 more
  • Oncological Follow-up
  • Amiens, France
  • +2 more
Aug 12, 2022

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Pancreatic Cyst, Pancreatic Tumors, Pancreatic Cancer Trial in San Francisco (Survey)

Recruiting
  • Pancreatic Cyst
  • +7 more
  • Survey
  • San Francisco, California
    University of California, San Francisco
Sep 20, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +32 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Acinar Cell Carcinoma, Ampulla of Vater Adenocarcinoma, Cholangiocarcinoma Trial in Cleveland, Philadelphia (Pancreatectomy,

Recruiting
  • Acinar Cell Carcinoma
  • +7 more
  • Pancreatectomy
  • Lavage
  • Cleveland, Ohio
  • +1 more
Sep 7, 2022

Mucinous Adenocarcinoma of the Rectum, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Rectum Trial in Richmond

Completed
  • Mucinous Adenocarcinoma of the Rectum
  • +9 more
  • intensity-modulated radiation therapy
  • +4 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Jul 19, 2021

Hereditary Pancreatic Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in Portland

Recruiting
  • Hereditary Pancreatic Carcinoma
  • +2 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • Ferumoxytol
  • Portland, Oregon
    OHSU Knight Cancer Institute
Aug 16, 2022

oncRNA Stratification of Cancer by Size and Stage

Not yet recruiting
  • Kidney Cancer
  • +32 more
  • Exai oncRNA blood test
  • (no location specified)
Apr 27, 2023

Colorectal Cancer Trial in Hangzhou (Carilizumab + anti-angiogenic TKIs (available with fuquitinib, rigofenib, apatinib, etc.),

Unknown status
  • Colorectal Cancer
  • Carilizumab + anti-angiogenic TKIs (available with fuquitinib, rigofenib, apatinib, etc.)
  • Carilizumab + anti-angiogenic TKIs (available with fuquitinib, rigofenib, apatinib, etc.)+Irinotecan
  • Hangzhou, Zhejiang, China
    Zhejiang Province Cancer Hospital
Jun 22, 2020

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022